Skip To Main Content
Sarah Childs on Muck Rack

Sarah Childs

Kitchener
As seen in: Nature, Wiley Online Library, Cambridge University Press & Assessment, Memory Studies, PLOS Biology, Taylor & Francis Online, BioRxiv, Temple University News, openDemocracy, King's College London and
Business Transformation Manager SSRP @yorkuniversity CIRPA Board. @thecarpentries instructor. ORCID 0000-0002-4450-4281 He/him
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sarah

Contact Sarah, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Fathers, mothers, and legislative talk about the future

|
By Chris Hanretty, Sarah Childs
| Taylor & Francis Online
?Mathematical formulae have been encoded as MathML and are displayed in this HTML version using MathJax in order to improve their display. Uncheck the box to turn MathJax off. This feature requires Javascript. Click on a formula to zoom. ABSTRACT Everyone agrees that legislators in democracies should have due regard for the future. However, we do not know what factors affect politicians’ temporal focus.
Open in Who Shared Issue with article?

What fish can reveal about brain blood vessels

|
By Sarah Childs
| The Naked Scientists Podcast - Stripping Down Science
A gene called FoxF2 has been linked to cerebral vascular problems, including strokes, although quite how it's involved in the disease process wasn't known. So what Sarah Childs and Faye Graff, at the University of Calgary, have done to try to learn more was to use gene editing to deplete the number of working copies of the gene in zebrafish.
Open in Who Shared Issue with article?

A roadmap for establishing institutional readiness for cellular therapies targeting solid tumours and autoimmune diseases

|
By Sarah Childs, David Ma, Elizabeth Houghton, Rasha Cosman, Jennifer Massey, Venessa T. Chin, Amanda L. McLaughlin, Simon Goodwin, Barbara Sheehan Withers, Callie Noakes, Annabel Horne, Jessica Boyd, Dion Forstner, Anthony J Rodrigues, Geeta Sandhu, Karim Ibrahim, Chloe Martin, Benjamin Kwan, Hergen Buscher, Philip J. Cunningham, Anthony M. Joshua, Laila Girgis, Ben Tran, Jayesh Desai, Simon Harrison, John Moore, Jia Liu, Valerie Valencia, Aaron O’Grady, Simone Kay Jensen, Helen Tao, Paul Preisz, Nicolas De Luca
| Nature Verified
Abstract Adoptive cellular therapies have revolutionised treatment of haematological malignancies and demonstrate potential in solid tumours and autoimmune disease. Real-world implementation remains limited by biological, logistical, and manufacturing barriers, restricting global uptake despite a rapidly expanding clinical trial portfolio. Effective implementation requires national and institutional readiness, multidisciplinary collaboration, scalable manufacturing, and robust infrastructure.
Open in Who Shared Issue with article?
See all 20 licensed articles (21 Total)